CN Stock MarketDetailed Quotes

Liaoning Chengda Biotechnology (688739)

Watchlist
  • 24.41
  • -0.50-2.01%
Market Closed Apr 3 15:00 CST
10.17BMarket Cap57.17P/E (TTM)

Liaoning Chengda Biotechnology (688739) Key Financial Indicators

688739 Earnings per Share (EPS)

According to the latest financial report of Liaoning Chengda Biotechnology, the latest earnings per share (TTM) for the company is 0.40. Investing in companies with strong earnings per share can potentially provide higher returns.

Currency: CNY

Cumulative Quarterly

Loading...

688739 Book Value Per Share (BVPS)

Analyzing a company's fundamentals? Check out Liaoning Chengda Biotechnology's latest financial report to see how much their book value per share (BVPS) is currently at 22.54.

Currency: CNY

Cumulative Quarterly

Loading...

688739 Current Ratio

If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Liaoning Chengda Biotechnology shows that the company's current ratio is 20.69, indicating healthy liquidity.

Currency: CNY

Cumulative Quarterly

Loading...

688739 Quick Ratio

Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Liaoning Chengda Biotechnology, the quick ratio is 19.28, indicating that the company can meet its short-term debt obligations.

Currency: CNY

Cumulative Quarterly

Loading...

688739 Return on Equity (ROE)

Want to learn more about the financial health of Liaoning Chengda Biotechnology? The latest ROE figure is 1.74%, indicating that the company has stable profitability.

Currency: CNY

Cumulative Quarterly

Loading...

688739 Return on Assets (ROA)

Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Liaoning Chengda Biotechnology, the total asset return on investment (ROA) is 1.66%.

Currency: CNY

Cumulative Quarterly

Loading...

688739 Gross Margin

Gross margin can provide insight into a company's pricing strategy and cost structure. Check Liaoning Chengda Biotechnology's latest financial report to see how their gross margin is doing - currently at 79.63%.

Currency: CNY

Cumulative Quarterly

Loading...

688739 Net Margin

For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Liaoning Chengda Biotechnology, the net profit margin is 15.04%, which is a good sign for its profitability.

Currency: CNY

Cumulative Quarterly

Loading...

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
On April 3rd Eastern Time, the US-Iran conflict entered its 35th day. Iran rejected the US's 48-hour ceasefire proposal and launched a fierc Show More